OA09250A - "New compositions and new pharmaceuticals ensuring the regeneration of leukocytes and their use in the treatment of immune deficiency syndrome". - Google Patents

"New compositions and new pharmaceuticals ensuring the regeneration of leukocytes and their use in the treatment of immune deficiency syndrome".

Info

Publication number
OA09250A
OA09250A OA59701A OA59701A OA09250A OA 09250 A OA09250 A OA 09250A OA 59701 A OA59701 A OA 59701A OA 59701 A OA59701 A OA 59701A OA 09250 A OA09250 A OA 09250A
Authority
OA
OAPI
Prior art keywords
new
leukocytes
regeneration
ensuring
treatment
Prior art date
Application number
OA59701A
Other languages
French (fr)
Inventor
Dietlin Francois
Fredj Daniele
Original Assignee
Rech Newpharm Soc Civ De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rech Newpharm Soc Civ De filed Critical Rech Newpharm Soc Civ De
Publication of OA09250A publication Critical patent/OA09250A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • C07D219/10Nitrogen atoms attached in position 9

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA59701A 1988-12-19 1989-12-19 "New compositions and new pharmaceuticals ensuring the regeneration of leukocytes and their use in the treatment of immune deficiency syndrome". OA09250A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR888816749A FR2640508B1 (en) 1988-12-19 1988-12-19 NOVEL COMPOSITIONS AND NEW PHARMACEUTICAL PRODUCTS ENSURING THE REGENERATION OF LEUKOCYTES AND THEIR USE FOR THE TREATMENT OF IMMUNE DEFICIT SYNDROME

Publications (1)

Publication Number Publication Date
OA09250A true OA09250A (en) 1992-06-30

Family

ID=9373109

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59701A OA09250A (en) 1988-12-19 1989-12-19 "New compositions and new pharmaceuticals ensuring the regeneration of leukocytes and their use in the treatment of immune deficiency syndrome".

Country Status (19)

Country Link
EP (1) EP0375471B1 (en)
JP (1) JPH02258722A (en)
KR (1) KR900009075A (en)
AP (1) AP125A (en)
AT (1) ATE136463T1 (en)
AU (2) AU4686189A (en)
CA (1) CA2005925C (en)
DE (1) DE68926222D1 (en)
DK (1) DK646489A (en)
FR (1) FR2640508B1 (en)
HU (1) HU213510B (en)
IL (1) IL92759A (en)
MA (1) MA21964A1 (en)
MY (1) MY106032A (en)
NZ (1) NZ231854A (en)
OA (1) OA09250A (en)
PT (1) PT92620B (en)
TN (1) TNSN89135A1 (en)
ZA (1) ZA899733B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155226A (en) * 1991-02-19 1992-10-13 Hoechst-Roussel Pharmaceuticals Incorporated Method for the preparation of 9-amino-1,2,3,4-tetrahydroacridine
EP0509401A1 (en) * 1991-04-19 1992-10-21 Hoechst-Roussel Pharmaceuticals Incorporated Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
RU2036198C1 (en) * 1993-04-01 1995-05-27 Товарищество с ограниченной ответственностью "Полисан" N-METHYL- N- (α-D- GLUCOPYRANOSYL) -AMMONIUM -2-(ACRIDONE -9-ONE -10-YL) -ACETATE (CYCLOFERON) SHOWING INTERFEROGENIC, ANTIVIRAL AMONG THEM ANTI-HIV, ANTIPARASITIC, ANTIPROMOTER AND RADIOPROTECTIVE ACTIVITIES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916122A (en) * 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
EP0332626A1 (en) * 1986-11-21 1989-09-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Compositions for treating viral infections in humans
IL86009A (en) * 1987-04-10 1991-09-16 Us Health Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases
US5013741A (en) * 1987-09-08 1991-05-07 Hoechst-Roussel Pharmaceuticals Incorporated N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal
US4985430A (en) * 1987-12-03 1991-01-15 Mitsubishi Kasei Corporation 9-acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient
CH678275A5 (en) * 1989-05-25 1991-08-30 Debiopharm Sa
US4999358A (en) * 1989-06-26 1991-03-12 Hoechst-Roussel Pharmaceuticals Inc. (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds
US4999430A (en) * 1989-07-31 1991-03-12 Warner-Lambert Company Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine

Also Published As

Publication number Publication date
MY106032A (en) 1995-02-28
CA2005925C (en) 2002-03-26
DE68926222D1 (en) 1996-05-15
HU213510B (en) 1997-07-28
EP0375471A3 (en) 1992-07-08
AP8900157A0 (en) 1990-01-31
AP125A (en) 1991-03-19
EP0375471A2 (en) 1990-06-27
AU666725B2 (en) 1996-02-22
ZA899733B (en) 1991-04-24
ATE136463T1 (en) 1996-04-15
CA2005925A1 (en) 1990-06-19
PT92620A (en) 1990-06-29
IL92759A0 (en) 1990-09-17
TNSN89135A1 (en) 1991-02-04
HU896683D0 (en) 1990-02-28
FR2640508B1 (en) 1994-07-01
EP0375471B1 (en) 1996-04-10
JPH02258722A (en) 1990-10-19
AU3980693A (en) 1993-08-19
DK646489D0 (en) 1989-12-19
FR2640508A1 (en) 1990-06-22
MA21964A1 (en) 1991-07-01
PT92620B (en) 1995-09-12
NZ231854A (en) 1993-01-27
KR900009075A (en) 1990-07-02
AU4686189A (en) 1990-06-21
IL92759A (en) 1994-06-24
DK646489A (en) 1990-06-20

Similar Documents

Publication Publication Date Title
EP0605024A3 (en) Use of purified surface modifiers to avoid aggregation of particles during sterilization.
MA21129A1 (en) AN IMPACT MODIFIER IN THE USE OF SMOKING ARTICLES
OA08617A (en) Neutral metalloendopeptidase inhibitors in the treatment of hypertention.
EP0270690A4 (en) MEDICINE FOR THE TREATMENT AND PROPHYLAXIS OF KIDNEY AND LIVER DISEASES.
FR2462167B1 (en) INTERFERON OF HUMAN FIBROPLASTS IN THE FORM OF A HOMOGENEOUS PROTEIN AND ITS PREPARATION
OA07925A (en) Food product effective in the treatment of leprosy.
FR2455572B1 (en) PHENYLETHYLAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS, AND COMPOSITIONS CONTAINING THEM
FR2717080B1 (en) Use of eipriprodil and its enantiomers for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative diseases.
ATE67783T1 (en) HOMOGENEOUS RECOMBINANT IMMUNE INTERFERON FRAGMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
OA09250A (en) "New compositions and new pharmaceuticals ensuring the regeneration of leukocytes and their use in the treatment of immune deficiency syndrome".
IT8619032A0 (en) IMPROVEMENTS MADE TO THE TREATMENT OF PARTICULATE MATERIALS.
FR2612775B1 (en) COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF SKIN DEGENERATION
IT1234230B (en) Camphor benzylidene sulphonamides deriving from amino acids and their use in cosmetics particularly as solar filters
FI922428A0 (en) NYA 2-AMINO-5-CYAN-1,4-DIHYDROPYRIDINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL.
FR2584074B1 (en) 5,6-EPOXY-7-OXABICYCLOHEPTANE ETHERS USEFUL IN THE TREATMENT OF THROMBOSES
FR2684552B1 (en) USE OF D-FENFLURAMINE AND FENFLURAMINE DERIVATIVES IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS.
DE3886371D1 (en) MANUFACTURE OF HBLV VIRUS IN THE HSB-2 CELL LINE.
FR2724935B1 (en) NANOPARTICLE COMPOSITIONS CONTAINING NUCLEOTIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS
FR2511597B1 (en) PRODUCTS EXTRACTED FROM MARINE INVERTEBERS, THEIR PREPARATION AND THEIR APPLICATIONS IN DIETETICS AND COSMETOLOGY
FR2663539B1 (en) USE OF D-FENFLURAMINE FOR OBTAINING MEDICINES FOR THE TREATMENT OF IMMUNE DEFICIENCIES IN THE AGED SUBJECT.
FR2505825B1 (en) ISOPRENYLAMINE DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS
FR2709964B1 (en) Antiviral pharmaceutical compositions proposed in the treatment of AIDS and Herpes.
FR2542744B2 (en) 3 ', 5'-DIARABINOSIDES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
EP0871472A4 (en) CYTOKINES AND THEIR USE IN THE TREATMENT AND / OR PROPHYLAXIS OF BREAST CANCER